Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1667-1677
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1667
Table 3 Changes of the main indicators of the included patients after treatment

The test arm (n = 24)
The control arm (n = 16)
P value
Body mass index, kg/m2-0.2 (-0.9-1.5)0.0 (0.0-0.5)0.281
Child–Pugh score-1.5 [-3.0-(-0.5)]0 (-0.5-1.5)0.001
Child–Pugh class (from B or C to A), n (%)8 (33.3)1 (6.3)0.048
End-diastolic volume of the left ventricle, mL-13 [-17-(-10)]0 (-3-12)< 0.001
Ejection fraction of the left ventricle, %0.5 (-0.7-0.3)0.0 (0.0-0.3)0.590
Stroke volume, mL-7 [-12-(-4)]0 (-3-8)< 0.001
Heart rate, bpm2 (-4-8)-2 (-7-7)0.234
Cardiac output, L/min-0.5 [-1.0-(-0.1)]0.3 (-0.3-0.9)0.026
Mean blood pressure, mmHg1.8 (-1.7-7.5)3.8 (-3.3-15.3)0.847
Systemic vascular resistance, dyn· s· cm−5237 (39-358)30 (-200-227)0.026
Mean pulmonary artery pressure, mmHg0.0 (-2.1-0.6)1.2 (0.0-1.8)0.043
Esophageal varices, a decrease in grade, n (%)2 (4.3)00.354
Esophageal varices, an increase in grade, n (%)00-
Regression hepatic encephalopathy, n (%)8 (33.3)1 (6.3)0,048
Ascites, a decrease in degree, n (%)15 (62.4)4 (25.0)0.022
Ascites, an increase in degree, n (%)1 (4.2)3 (18.8)0.167
Red blood cells as 1012 cell/L0.2 (-0.1-0.5)0.2 (-0.1-0.4)0.730
White blood cells as 109 cell/L0.1 (-1.2-0.6)-0.1 (-2.1-0.7)0.782
Platelets as 109 cell/ L11 (4-32)-6 (-14-1)< 0.001
Serum total protein, g/L-0.2 (-4.2-8.9)-1.4 (-3.5-5.6)0.793
Serum albumin, g/L3.0 (0.6-7.7)-3.1 (-5.1-2.4)0.001
Serum total bilirubin, μmol/L-5.1 [-23.9-(-0.9)]-3.7 (-10.0-17.2)0.181
International normalized ratio0.0 (-0.1-0.1)0.0 (-1.0-0.1)0.544
Serum cholesterol, mmol/L0.2 (-0.4-1.2)0.5 (-1.0-2.0)0.571
Serum triglyceride, mmol/L0.1 (-0.2-0.2)0.1 (-0.6-0.4)0.836
Serum creatinine, mg/dL2.4 (-9.1-8.1)-3.5 (-11.2-4.2)0.264
Serum sodium, mmol/L1.5 (0.5-3.0)-1 (-3-2)0.048
Serum potassium, mmol/L0.0 (-0.4-1.2)0.1 (-0.2-0.3)0.523
Serum glucose, mmol/L0.4 (-0.1-0.7)0.0 (-0.9-0.8)0.423
Alanine aminotransferase, U/L-1 (-15-6)2 (-15-8)0.740
Aspartate aminotransferase, U/L-9 (-32-1)-2 (-26-20)0.116
Gamma glutamyl transferase, U/L-8 (-171-11)6 (-15-23)0.039
Alkaline phosphatase, U/L-40 (-95-3)26 (-57-91)0.016
Cholinesterase, U/L257 (28-734)-155 [-239-(-68)]0.016
C-reactive protein, mg/L-3.0 [-4.5-(-0.5)]1.0 (-2.0-4.5)0.044